115 related articles for article (PubMed ID: 11240436)
1. [Optimization of aerosol therapy in otorhinolaryngology: stability and granulometry of dexamethasone-gomenol-framycetin solution].
Bellanger A; Becquemin MH; Feldman D; Bertholon JF; Tankere F
Ann Otolaryngol Chir Cervicofac; 2001 Feb; 118(1):45-53. PubMed ID: 11240436
[TBL] [Abstract][Full Text] [Related]
2. The compatibility and stability of midazolam and dexamethasone in infusion solutions.
Good PD; Schneider JJ; Ravenscroft PJ
J Pain Symptom Manage; 2004 May; 27(5):471-5. PubMed ID: 15120775
[TBL] [Abstract][Full Text] [Related]
3. [Nebulization aerosol therapy in otorhinolaryngology. Review of the literature].
Bonfils P
Ann Otolaryngol Chir Cervicofac; 1997; 114(5):147-56. PubMed ID: 9686025
[TBL] [Abstract][Full Text] [Related]
4. [Best clinical practices for aerosol nebulization therapy approved at the National Meeting on Nebulization, Paris 4-5 April 1997].
Dautzenberg B; Bonfils P; Diot P; Faurisson F; Fauroux B
Ann Otolaryngol Chir Cervicofac; 2000 Nov; 117(5):327-32. PubMed ID: 11084407
[No Abstract] [Full Text] [Related]
5. [Practice guidelines of aerosol therapy through nebulization. Proposals from the National Assizes on Nebulization, Paris, April 4-5, 1997 (version from September 15 1997)].
Arch Pediatr; 1998 Feb; 5(2):175-80. PubMed ID: 10223140
[TBL] [Abstract][Full Text] [Related]
6. Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients.
Negro S; Salama A; Sánchez Y; Azuara ML; Barcia E
J Clin Pharm Ther; 2007 Oct; 32(5):441-4. PubMed ID: 17875108
[TBL] [Abstract][Full Text] [Related]
7. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
[TBL] [Abstract][Full Text] [Related]
8. Stability and characterization of perphenazine aerosols generated using the capillary aerosol generator.
Li X; Blondino FE; Hindle M; Soine WH; Byron PR
Int J Pharm; 2005 Oct; 303(1-2):113-24. PubMed ID: 16139453
[TBL] [Abstract][Full Text] [Related]
9. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol.
Dhand R
Respir Care; 2002 Dec; 47(12):1406-16; discussion 1416-8. PubMed ID: 12467499
[TBL] [Abstract][Full Text] [Related]
10. [Aerosol therapy with a new antibiotic, lincomycin, in ORL disorders].
Montiglio PE
Minerva Otorinolaringol; 1969; 19(1):57-9. PubMed ID: 5405800
[No Abstract] [Full Text] [Related]
11. [Proposals for the best use of aerosol therapy using nebulization. Decision of the National Conference on Nebulization. Paris, 4-5 April 1997 (15 September 1997 release)].
Rev Mal Respir; 1997 Dec; 14(6):512-6. PubMed ID: 9496615
[No Abstract] [Full Text] [Related]
12. A miniaturized nebulization catheter for improved gene delivery to the mouse lung.
Köping-Höggård M; Issa MM; Köhler T; Tronde A; Vårum KM; Artursson P
J Gene Med; 2005 Sep; 7(9):1215-22. PubMed ID: 15895386
[TBL] [Abstract][Full Text] [Related]
13. Characterization of antimicrobial aerosols for administration to horses.
McKenzie HC
Vet Ther; 2003; 4(2):110-9. PubMed ID: 14506586
[TBL] [Abstract][Full Text] [Related]
14. Comparison between direct humidification and nebulization of the respiratory tract at mechanical ventilation: distribution of saline solution studied by gamma camera.
Klockare M; Dufva A; Danielsson AM; Hatherly R; Larsson S; Jacobsson H; Mure M
J Clin Nurs; 2006 Mar; 15(3):301-7. PubMed ID: 16466479
[TBL] [Abstract][Full Text] [Related]
15. [Multicenter study of neoparyl-framycetin collyrium. Statistical analysis of the results].
Mawas E
Bull Soc Ophtalmol Fr; 1982; 82(6-7):823-5. PubMed ID: 6756661
[No Abstract] [Full Text] [Related]
16. [The role of nebulizer therapy in acute laryngeal inflammation].
Antoniv VF; Gribanova AG; Kazanova NI; El'kun GB; Rusanova EV; Chernolev AI
Vestn Otorinolaringol; 2006; (3):16-8. PubMed ID: 16912667
[TBL] [Abstract][Full Text] [Related]
17. New ipratropium formulation to decrease nebulization time.
Majoral C; Vecellio L; Grimbert D; de Monte M; le Guellec C; Ingremeau V; Minois C; Cordeau E; Paintaud G; Steinberg A; Diot P
Respir Med; 2007 Feb; 101(2):237-45. PubMed ID: 16854578
[TBL] [Abstract][Full Text] [Related]
18. [Clinical observations on the use of rifamycin SV by aerosol in otorhinolaryngology].
Amorelli A
Arch Ital Laringol; 1965; 73(1):21-8. PubMed ID: 5325013
[No Abstract] [Full Text] [Related]
19. Formulations and nebulizer performance.
O'Riordan TG
Respir Care; 2002 Nov; 47(11):1305-12; discussion 1312-3. PubMed ID: 12425745
[TBL] [Abstract][Full Text] [Related]
20. [Rhinoparyl in otorhinolaryngology].
Flottes L; Riu R; Le Mouel C
Rev Laryngol Otol Rhinol (Bord); 1965; 86(9):772-88. PubMed ID: 5851575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
